Jean‐François Emile
Inserm(FR)Université de Versailles Saint-Quentin-en-Yvelines(FR)Université Paris Cité(FR)Université Paris-Saclay(FR)CHU Ambroise Paré(BE)Sorbonne Université(FR)Centre de Recherche des Cordeliers(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Hôpital Ambroise-Paré(FR)Laboratoire d’immunologie intégrative du cancer(FR)Center for Migration Studies of New York(US)Université d'été de Boulogne-sur-Mer(FR)Biomarqueurs et essais cliniques en Cancérologie et Onco-Hématologie(FR)
Publications by Year
Research Areas
Histiocytic Disorders and Treatments, Colorectal Cancer Treatments and Studies, Genetic factors in colorectal cancer, Mast cells and histamine, Parvovirus B19 Infection Studies
Most-Cited Works
- → The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms(2022)3,646 cited
- → KRAS Mutation Status Is Predictive of Response to Cetuximab Therapy in Colorectal Cancer(2006)2,215 cited
- → Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages(2016)1,526 cited
- → KRAS Mutations As an Independent Prognostic Factor in Patients With Advanced Colorectal Cancer Treated With Cetuximab(2008)1,450 cited
- → Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection(1996)876 cited
- → Impairment of Mycobacterial Immunity in Human Interleukin-12 Receptor Deficiency(1998)840 cited